Maternal Serum Screen – Triple Test

3,000.00

Categories: ,

The Triple Marker Test (also known as the Maternal Serum Triple Screen) is a prenatal blood test performed during the second trimester of pregnancy, usually between 15 and 20 weeks of gestation. It measures the levels of three important substances in the mother’s blood:
1. Alpha-fetoprotein (AFP) – a protein made by the baby’s liver
2. Human chorionic gonadotropin (hCG) – a hormone produced by the placenta
3. Unconjugated estriol (uE3) – an estrogen produced by the placenta and the baby
These markers help assess the risk of certain genetic and developmental conditions in the fetus.

Description

Why It’s Done:
The Triple Marker Test is a screening tool used to evaluate the likelihood of fetal abnormalities, such as:
• Down syndrome (Trisomy 21)
• Trisomy 18 (Edwards syndrome)
• Neural tube defects like spina bifida and anencephaly

Preparation:
• No fasting or special preparation is needed.
• A blood sample will be drawn from a vein in your arm.
• Inform your doctor of your exact gestational age, weight, ethnic background, and whether you’re carrying more than one baby, as these factors influence the interpretation of the results.